All In Biotech

Drug Trial Radar · NCT06962098

Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

A Phase 2b Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Evaluate the Efficacy and Safety of Isuzinaxib in Subjects With Diabetic Kidney Disease

Last checked: Nov 20, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 186 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

186

Planned (sponsor's estimate)

Start

May 26, 2025

Primary completion

Jun 30, 2027

Study completion Jun 30, 2028

Sponsor

Lead sponsor
Aptabio Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter, double-blinded, randomized, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, PK, and efficacy of Isuzinaxib compared with placebo in subjects with DKD.

Conditions

  • Diabetic Kidney Disease (DKD)

Interventions

  • IsuzinaxibDrug

    Oral dosing regimen once daily

  • PlaceboDrug

    Oral dosing regimen once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy endpoint: Urine Albumin-Creatinine RatioTime frame: Over 24 Weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Korea University Ansan Hospital

    Ansan-si, South Korea · Recruiting

  • Inje university Busan Paik Hospital

    Busan, South Korea · Not yet recruiting

  • Pusan National University Hospital

    Busan, South Korea · Recruiting

  • SoonChunHyang University Hospital Cheonan

    Cheonan, South Korea · Recruiting

  • Keimyung University Daegu Dongsan Hospital

    Daegu, South Korea · Recruiting

  • Inje university Ilsan Paik Hospital

    Goyang-si, South Korea · Recruiting

  • Hanyang University Guri Hospital

    Guri-si, South Korea · Recruiting

  • Chung-Ang University Gwangmyeong Hospital

    Gwangmyeong, South Korea · Recruiting

  • The Catholic University of Korea Incheon St. Mary's Hospital

    Incheon, South Korea · Recruiting

  • Jeonbuk National University Hospital

    Jeonju, South Korea · Not yet recruiting

  • CHA Bundang Medical Center

    Seongnam-si, South Korea · Recruiting

  • Boramae Medical Center

    Seoul, South Korea · Recruiting

  • Korea University Guro Hospital

    Seoul, South Korea · Recruiting

  • Kyung Hee University Hospital at Gangdon

    Seoul, South Korea · Recruiting

  • Seoul National University Hospital

    Seoul, South Korea · Recruiting

  • Severance Hospital

    Seoul, South Korea · Recruiting

  • The Catholic University of Korea Seoul ST.MARY'S Hospital

    Seoul, South Korea · Recruiting

  • The Catholic University of Korea Uijeongbu St. Mary's Hospital

    Uijeongbu-si, South Korea · Recruiting

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea · Not yet recruiting

  • Pusan National University Yangsan Hospital

    Yangsan, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.